Differences Between Conductive vs Sensorineural Hearing Loss
Conductive hearing loss originates from problems in the outer or middle ear that block sound transmission to the inner ear, while sensorineural hearing loss results from damage to the cochlea, auditory nerve, or central auditory pathways 1.
Anatomical Location and Pathophysiology
Conductive Hearing Loss (CHL):
- Involves the external auditory canal, tympanic membrane, or ossicular chain
- Sound waves cannot efficiently reach the inner ear due to mechanical obstruction or dysfunction
- The cochlea and neural pathways remain intact
- Common causes include cerumen impaction, middle ear effusion, otosclerosis, and tympanic membrane perforation 2
Sensorineural Hearing Loss (SNHL):
- Arises from abnormalities of the cochlea (hair cell degeneration), auditory nerve, or higher central auditory processing centers 1
- In age-related hearing loss, hair cell loss starting at the basal turn is now recognized as the primary mechanism, rather than strial atrophy as previously thought 1, 3
- Neural hearing loss specifically affects speech discrimination due to neuronal loss 1
Clinical Presentation Patterns
Key distinguishing features:
CHL typically presents with:
- Better hearing in noisy environments (paradoxically)
- Normal or near-normal speech discrimination when sound is loud enough
- Often unilateral or asymmetric presentation
- Association with craniofacial anomalies in congenital cases 4
SNHL characteristically shows:
Diagnostic Differentiation
The air-bone gap is the definitive diagnostic criterion:
CHL: Significant gap (>10-15 dB) between air conduction (AC) and bone conduction (BC) thresholds on audiometry. AC thresholds are elevated while BC thresholds remain normal 2, 5
SNHL: AC and BC thresholds are similarly elevated with minimal or no air-bone gap (<10 dB) 2, 5
Mixed hearing loss: Both components present—elevated BC thresholds with an additional air-bone gap 2
The bone vibrator bypasses the middle ear and directly stimulates the cochlea, which is why BC testing remains normal in pure CHL 5. Recent evidence confirms that soft tissue conduction (STC) thresholds parallel BC thresholds and can contribute to differential diagnosis when mastoid application is not feasible 5.
Severity and Laterality Patterns
Important clinical distinctions:
SNHL in infants occurs bilaterally almost 3 times more often than unilaterally and tends to be severe to profound (45% of cases) 4
CHL is more commonly mild in severity and can be unilateral or bilateral 4
This severity difference has major implications for rehabilitation urgency and approach
Rehabilitation Outcomes
Hearing aid performance differs significantly:
Patients with CHL demonstrate consistently higher speech perception scores after hearing aid fitting, particularly in noise 6
Patients with SNHL show persistently poorer outcomes, especially for speech-in-noise perception, even with appropriately fitted amplification 6
At 3 months post-fitting, SNHL patients scored significantly lower in noise conditions (β = -1.73; 95% CI: -3.10 to -0.36; p = 0.014) 6
This performance gap exists because CHL involves only amplification deficits (the cochlea works normally once sound reaches it), while SNHL involves damaged sensory cells and neural processing that cannot be fully compensated by simple amplification 6.
Clinical Implications for Management
Treatment approaches diverge fundamentally:
CHL: Often surgically correctable (e.g., tympanoplasty, ossiculoplasty, stapedectomy) or medically treatable (cerumen removal, treating otitis media). Hearing aids provide excellent benefit when surgery is not indicated 2
SNHL: Requires auditory rehabilitation with hearing aids as first-line treatment. When appropriately fitted amplification fails to provide adequate speech understanding, cochlear implantation candidacy should be evaluated 1
Critical pitfall: Sudden sensorineural hearing loss (≥30 dB loss within 72 hours) requires urgent otolaryngology referral and potential corticosteroid treatment, whereas sudden CHL does not carry the same urgency 7, 2.
Impact on Quality of Life
Both untreated CHL and SNHL negatively affect communication, safety, cognition, and quality of life, but the mechanisms differ 1. SNHL, particularly age-related hearing loss, carries documented associations with dementia, depression, cardiovascular disease, falls, unemployment, and social isolation 1, 3. These downstream effects emphasize the importance of early identification and treatment, with assessment recommended at least every 3 years in patients with known hearing loss 1.
Bone-anchored hearing implant users with CHL report significantly greater quality of life benefits compared to those with unilateral SNHL, particularly in communication ease, sound clarity, and overall health status (p < 0.00001 for multiple domains) 8.